0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Aidan Power, MB, BCh, MRC Psych; Adam C. Berger, PhD; Geoffrey S. Ginsburg, MD, PhD
JAMA. 2014;311(20):2063-2064. doi:10.1001/jama.2014.3002.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(12):1192. doi:10.1001/jama.2014.3085.

Viewpoint | 
Vinay Prasad, MD; Sham Mailankody, MB, BS
JAMA. 2014;311(4):353-354. doi:10.1001/jama.2013.284531.

Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(3):233-234. doi:10.1001/jama.2013.284833.

Viewpoint | 
Jacob Doll, MD; Emily Zeitler, MD; Richard Becker, MD
JAMA. 2013;310(2):145-146. doi:10.1001/jama.2013.7155.

Special Communication | 
Bruce R. Korf, MD, PhD; Heidi L. Rehm, PhD
JAMA. 2013;309(14):1511-1521. doi:10.1001/jama.2013.3239.
Includes: CME

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(1):20. doi:10.1001/jama.2012.173440.

Viewpoint | 
Michael Pacanowski, PharmD, MPH; Shashi Amur, PhD; Issam Zineh, PharmD, MPH
JAMA. 2012;307(18):1921-1922. doi:10.1001/jama.2012.3516.

Editorial | 
Steven E. Nissen, MD
JAMA. 2011;306(24):2727-2728. doi:10.1001/jama.2011.1865.

Commentary | 
Amber L. Beitelshees, PharmD, MPH; David L. Veenstra, PharmD, PhD
JAMA. 2011;306(11):1252-1253. doi:10.1001/jama.2011.1343.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Evidence to Practice  | 
The Comparative Clinical Effectiveness and Value of Simeprevir and Sofosbuvir for Chronic Hepatitis C Virus Infection
Daniel A. Ollendorf, MPH; Jeffrey A. Tice, MD; Steven D. Pearson, MD, MSc
JAMA Dermatology
Observation  | 
Spindle Cell Squamous Carcinoma During BRAF Inhibitor Therapy for Advanced Melanoma:  An Aggressive Secondary Neoplasm of Undetermined Biologic Potential
Daniel N. Cohen, MD, PhD; Wilfred A. Lumbang, MD; Alan S. Boyd, MD; et al.
JAMA Ophthalmology
Original Investigation  | 
VEGFA and VEGFR2 Gene Polymorphisms and Response to Anti–Vascular Endothelial Growth Factor Therapy:  Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
Stephanie A. Hagstrom, PhD; Gui-shuang Ying, PhD; Gayle J. T. Pauer, BA; et al.
JAMA Dermatology
Case Report/Case Series  | 
Identification of a Novel Complex BRAF Mutation Associated With Major Clinical Response to Vemurafenib in a Patient With Metastatic Melanoma
Benoit Busser, PharmD, PhD; Marie Therese Leccia, MD, PhD; Guillaume Gras-Combe, MD; et al.